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http:WHAT THIS PAPER ADDS
The present study is the ﬁrst in the literature focussing on the complex interaction between carotid plaques and
stents by analysing OCT (optical coherence tomography) ﬁndings (stent malapposition, plaque prolapse and cap
rupture) according to stent design.
The results of this investigation offer some original and unexpected information, which is available for the ﬁrst
time at such a high deﬁnition, and that may inﬂuence our future clinical policies in patients with carotid artery
disease.Objectives: This study aims to evaluate the rate of stent malapposition, plaque prolapse and ﬁbrous cap rupture
detected by optical coherence tomography (OCT) imaging according to carotid stent design.
Design: It was a prospective single-centre study.
Materials and methods: Forty consecutive patients undergoing protected carotid artery stenting (CAS) and high-
deﬁnition OCT image acquisition were enrolled in the study. OCT frames were analysed off-line, in a dedicated
core laboratory by two independent physicians. Cross-sectional OCT images within the stented segment of the
internal carotid artery were evaluated at 1-mm intervals for the presence of strut malapposition, plaque prolapse
and ﬁbrous cap rupture according to stent design.
Results: Closed-cell design stents (CC) were used in 17 patients (42.5%), open-cell design stents (OC) in 13
(32.5%) and hybrid design stents (Hyb) in 10 (25%). No procedural or post-procedural neurological complications
occurred (stroke/death 0% at 30 days). On OCT analysis the frequencies of malapposed struts were higher with
CC compared to OC and Hyb (34.5% vs 15% and 16.3%, respectively; p < 0.01). Plaque prolapse was more
frequent with OC vs CC (68.6% vs 23.3%; p < 0.01) and vs Hyb stents (30.8%; p < 0.01). Signiﬁcant differences
were also noted in the rates of ﬁbrous cap rupture between CC and OC (24.2% vs 43.8%; p < 0.01), and between
CC and Hyb (24.2% vs 39.6%; p < 0.01), but not between OC and Hyb stents (p ¼ 0.4).
Conclusion: Intravascular OCT after CAS revealed that micro-defects after stent deployment are frequent and are
related to the design of implanted stents. Stent malapposition is more frequent with CC stents, while plaque
prolapse is more common with OC stents.
It remains, however, unknown whether these ﬁgures now detected with OCT are of any clinical and prognostic
signiﬁcance.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2013.03.005based invasive intravascular imaging system that uses
near-infrared light with orders of magnitude higher than
those of medical ultrasound signals, providing unprece-
dented microstructural information on atherosclerotic pla-
ques. OCT is a progressively accepted intravascular modality
to study coronary arteries, stent implantation and vessel
injury, as it permits accurate measurements of luminal
architecture and provides insights into plaque coverage,
plaque prolapse, stent apposition, overlap and neo-intimal
thickening.1,2 The superiority of OCT as a modality in the
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strated;3 it is due to its ability to resolve small gaps between
the stent strut and the vessel wall, which are often missed
by intravascular ultrasound (IVUS).
Coronary stent-strut coverage and apposition have been
linked to the risk of stent thrombosis,4 and recent rando-
mised clinical trials have selected these variables detected
by OCT as their primary ‘end’ point,5 revealing new and
unexpected data.
Safety and feasibility of OCT applied to carotid arteries
have been recently reported, with both an occlusive and
a non-occlusive technique.6e11
There is great interest in the possibility to recognise
further details regarding the interaction between a carotid
plaque and a stent by OCT, considering that plaque prolapse
through the cell stent has been suggested as one of the
major causes of post-procedural complications following
carotid artery stenting (CAS) and that available peri-
procedural imaging systems (angiography, IVUS and duplex
ultrasound) may not be able to detect such micro-defects.
At present, three designs of carotid stents with distinctive
features are available: closed-cell (CC), open-cell (OC) and
hybrid (Hyb) cell design, and different rates of neurological
events after CAS have been previously reported according
to the stent design.
Unfortunately existing intra-procedural imaging systems
have not been able to clearly deﬁne and provide precise
details of the conformability of actual carotid stents to
lesion contours and vessel tortuosity after deployment
(deﬁned as stent apposition/malapposition) or of the ability
of the stent to effectively cover the plaque. High-resolution
OCT images might provide more satisfactory results, and
this prospective study is the ﬁrst to investigate the distri-
bution of such micro-defects after CAS according to stent
design.
The aim of this study is to evaluate the rate of stent
malapposition, plaque prolapse and ﬁbrous cap rupture
detected by OCT after CAS according to stent design.METHODS
This prospective study was performed in a single centre,
including 40 consecutive patients undergoing CAS during
two interval periods correlated to the availability of the OCT
catheters in our Department (ﬁrst 25 cases from March
2011 to July 2011 and the last 15 cases from January 2012
to March 2012).
The study protocol was approved by our ethics committee,
and written informed consent was obtained from all
patients. Inclusion criteria were a >80% asymptomatic
internal carotid artery (ICA) stenosis or a>70% symptomatic
ICA stenosis (NASCET (North American Symptomatic Carotid
Endarterectomy Trial) criteria12) in patients already consid-
ered eligible for endovascular treatment.13
During the same period 12 patients were excluded from
the study because of elevated serum creatinine levels
(>1.2 mg dl1, n ¼ 6), a positive history of contrast medium
intolerance (n ¼ 2) and severe tortuosity of the ICA distal tothe target lesion (n ¼ 4) evaluated by the operator as unﬁt
for safe OCT catheter advancement (see ‘OCT technique’
section).
Demographic variables, clinical ﬁgures and intra-operative
and follow-up data were prospectively collected by the
operating team in a dedicated database.
Lesion characteristics and plaque composition were
studied using duplex ultrasound images and classiﬁed
according to the Gray-Weale classiﬁcation14 (Type 1 pla-
ques: dominantly hypoechoic, Type 2 plaques: substantially
hypoechoic with small areas of hyperechoicity, Type 3 pla-
ques: dominantly hyperechoic with small areas of hypo-
echoicity, Type 4 plaques: uniformly hyperechoic and
homogeneous). A lesion comprising 2 craters of 3 mm
depth or with poorly deﬁned edges and a hazy appearance
was deﬁned as ulcerated.
Echo duplex and independent neurological examinations
of all patients were performed before the intervention, at
discharge and 30 days after the procedure. All patients
underwent a cerebral computed tomography/magnetic
resonance imaging (CT/MRI) scan before treatment,
whereas a post-procedural cerebral CT/MRI scan was only
scheduled in the case of a documented neurological
complication.
CAS technique
CAS was performed according to our standard technique,
which has been described previously.15 Brieﬂy, once the
common carotid artery is selectively engaged directly using
an appropriate 8-F guiding catheter, and a cerebral
protection device is deployed in a straight segment of the
extracranial portion of the ICA distal to the culprit lesion,
the ﬁrst OCT scan is performed during a non-occlusive ﬂush
(see ‘OCT technique’ section).
Carotid stenting is then carried out using self-expandable
stents in all cases. The stent diameter is selected according
to the ICA diameter (mean oversize of 1 mm), while stent
length is calculated to cover the entire carotid lesion (at
least 0.5 cm below and 0.5 cm above the target lesion). In
all cases post-dilatation of the stent is performed using
short dedicated balloons (maximum size 5.5/20 mm)
inﬂating to nominal pressure, considering 30% residual
stenosis as acceptable for technical success.
Description of the OCT technique
Carotid OCT images were acquired three times in each of
the 40 patients: before stent deployment, immediately after
stent placement and following dilatation of the stent.
The optical ﬁbre of the Lightlab FD-OCT system used for
the investigation is encapsulated within a rotating torque
wire (0.014-inch compatible) built in a rapid-exchange 2.6-F
catheter compatible with a 6-F guiding catheter. It acquires
100 frames s1, scanning a 55-mm artery segment in 2.7 s
(pullback speeds up to 20 mm s1).
Once the cerebral protection device is deployed in
a straight portion of the ICA distal to the culprit lesion, the
calibrated OCT catheter is advanced over the 0.014-inch
Figure 1. Analysis of cross-sectional OCT images within the stented
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lesion that needed to be scanned.
Pullbacks are started during a non-occlusive ﬂush,
mechanically injecting 24 ml of 50% saline diluted contrast
medium (Iodinoxanol: Visipaque 320 mg l ml1; GE
Healthcare, Cork, Ireland) at 6 ml s1, 750 psi, using an
automatic injection system (Mark V ProVis; Medrad Inc.) to
completely replace blood from the artery. Injections are
performed through an 8F guiding catheter with a minimum
internal lumen of 2.3 mm, placed just few centimetres
proximal to the carotid bifurcation.
Of note, the pullback is started approximately 1.5e2 s
after the injection of the diluted contrast medium, when
the absence of blood scattering and signal attenuation are
noted on the screen of the OCT system (real-time images).
After stent deployment the same OCT manoeuvres are
repeated; in particular, two further scans are performed
before and after stent dilatation.segment of the internal carotid artery evaluated at 1 mm intervals.
Details of slice evaluation for the presence of malapposition, pla-
que prolapse and ﬁbrous cap rupture are shown in the boxes.Qualitative and quantitative assessment of OCT images
All OCT frames were analysed off-line, in a dedicated core
laboratory, by two independent physicians (FS and PS). OCT
images were judged of good quality according to a previ-
ously reported protocol, based on the accuracy of vessel
wall identiﬁcation.11
OCT images after stent deployment and dilatation (third
scan) were speciﬁcally reviewed and analysed in each patient
for the purpose of this investigation according to the design
of the implanted stent. In particular cross-sectional OCT
images within the stented segment of the ICA were evalu-
ated at 1-mm intervals for the presence of malapposition,
plaque prolapse and ﬁbrous cap rupture (Fig. 1).
The term ‘malapposition’ was used when the distance
measured from the surface of the blooming (the inner and
outer contours of each strut reﬂection) to the lumen
contour was greater than the total thickness of the stent
strut þ one-half of the blooming.
Considering that carotid stent struts ranged from 0.106
to 0.186 mm,16 a strut was classiﬁed as ‘malapposed’ when
the distance measured was >200 mm (Fig. 2(a)) and ‘well
apposed’ when the distance measured ranged 10e200 mm
(Fig. 2(b)).
Stent struts were further deﬁned as ‘embebbed’ when
burying into the intima for almost the entire size of their
thickness (distance measured <10 mm, Fig. 2(c)).
Plaque prolapse after stenting was deﬁned as any
appreciable tissue prolapse between the stent struts
(Fig. 3(a)), while any discontinuity of the inner layer of the
plaque proﬁle was considered as a rupture of the ﬁbrous
cap (Fig. 3(b)).‘End’ points
The primary ‘end’ points of the study are the rate of stent
malapposition, plaque prolapse and ﬁbrous cap rupture
detected by OCT imaging after CAS, according to the design
of the implanted stent.Secondary ‘end’ points include: stroke or death rate at 30
days and any in-hospital adverse events.
Deﬁnition of stent design
The CC design refers to stents in which no regions of the
stent are free to move independently from adjacent
segments.
The OC design refers to stent designs in which some
individual segments of the stent are not attached to adja-
cent segments and can therefore move independently.
The Hyb design consists of proximal and distal segments
with an open-cell design (to maximise conformity) in
combination with a central CC segment (for plaque/
thrombus coverage).
Statistical analysis
Continuous variables are presented as mean þ standard
deviation (SD), and ManneWhitney and Student’s t-tests
were used, as appropriate. Differences in categorical vari-
ables were assessed using the c2 and Fisher’s exact tests.
All statistical analyses were performed using the statis-
tical software package Statistical Package for the Social
Sciences (SPSS) v.13 (SPSS Inc., Chicago, IL, USA) and Mat-
Lab v.7.0.1 (MathWorks).
RESULTS
Procedural results
CAS with OCT images acquisitions was performed in all 40
patients.
The data of plaque evaluation by OCT are provided in
Table 1.
Completion angiograms revealed successful revascular-
isation and <30% residual stenosis in each case. CC
stents were used in 17 procedures (42.5%) (Carotid Wall-
stent e Boston Scientiﬁc Corp, Natick, MA, USA e No.13;
Figure 2. Classiﬁcation of stent strut apposition. The distance between endoluminal edge of the strut and intima was measured. Based on
this value, struts were classiﬁed into 3 grades: “malapposed” (>200 mm), “well apposed” (10e200 mm), or “embebbed” (<10 mm).
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act e Abbott Vascular, Redwood City, CA, USA e No. 2), OC
stents in 13 (32.5%) (Precise e Cordis, Miami Lakes, FL, USA
e No. 9; Protégé e ev3, Plymouth, MN, USA e No. 4) and
Hyb stents in 10 (25%) (Cristallo Ideale e Medtronic/Inva-
tec, Santa Rosa, CA, USA e No. 10) (Table 2).
Table 3 summarises the patients’ demographic data,
neurological histories and carotid plaque characteristics
according to stent design.
No technical or neurological complications occurred
during OCT pullbacks. The mean procedural time was
50  11 min, and the total amount of contrast medium was
85  17 ml/patient (range 60e135).
No major procedural or post-procedural complications
occurred in the study population (any stroke/death 0% at 30
days). Two transient ischaemic attacks (TIAs) were recorded
in the post-operative period (one in the OC group, one in
the Hyb group).
During the hospitalisation period, kidney function was
carefully monitored to assess the consequences of the extra
amount of contrast media needed for OCT image acquisi-
tion. The estimated glomerular ﬁltration rate (eGFR)
remained stable in all patients (preoperative value
98  6.5 ml min1 1.73 m2 vs postoperative
92  7.4 ml min1 1.73 m2, p ¼ 0.9).Figure 3. a. Plaque prolapse between the stThe OCT images acquired after stent deployment and
dilatation were judged in all cases to be of appropriate
quality to allow the qualitative and quantitative assessment
of the primary ‘end’ points of the study.OCT analysis
OCT analysis within the stented segment of the ICA at 1-mm
intervals produced a mean of 20  5 slices in each patient
(Fig. 1). A total of 729 cross-sectional OCT images were
analysed to assess the rate for stent apposition, plaque
prolapse and ﬁbrous cap rupture.
A mean of 28  2 stent struts were detected in each
slice, for a total of 20,412 struts evaluated.
Inter-observer variability was very good for identiﬁcation
of stent apposition (k¼ 0.84), plaque prolapse (k¼ 0.85) and
rupture of the ﬁbrous cap (k ¼ 0.81). Intra-observer agree-
ment, evaluated asking each observer to assess twice the
images within a 7-day interval, was excellent (k ¼ 0.95).
The results of stent malapposition, plaque prolapse and
rupture of ﬁbrous cap are presented on a slice-based
analysis and on a patient-based analysis. Data on stent
malapposition are also reported on a strut-based analysis.
In the strut-based analysis (Table 4), an average of 34.5%
struts were ‘malapposed’ in the CC group, compared to 15%ent struts; b. rupture of the ﬁbrous cap.
Table 1. OCT ﬁndings at ﬁrst pullback.
Diameter stenosis (mean %) 81%  4
Calciﬁcationa (no., %) 18 (45%)
Lipid-Rich Plaqueb (no., %) 26 (65%)
Ulcerated Plaquec (no., %) 11 (27.5%)
Thrombusd (no., %) 4 (10%)
a Heterogeneous, sharply delineated, signal-poor or signal-rich
region, or alternating signal-poor and signal-rich regions.
b Homogeneous, diffusely bordered, signal-poor region with an
overlying signalrich band corresponding to a ﬁbrous cap.
c A cavity with a lacerated superﬁcial intimal layer.
d A backscattering protrusion into the carotid lumen with signal-
intensity-free shadowing.
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(p < 0.001). Stent struts were found to be ‘embebbed’ into
the intima in 9% of the CC stent group, compared to 27% of
the OC stent and 25.6% of the Hyb stent groups (p < 0.001).
In the slice-based analysis (Table 5), the frequencies of
slices with at least ﬁve malapposed struts were higher in
the CC stents compared to OC and Hyb stents (29.8%
vs 13.2% and 14.8%, respectively; p < 0.01).
Plaque prolapse was signiﬁcantly less frequent with the
CC (23.3%) and with Hyb (30.8%) compared to the OC
stents (68.6%; p < 0.01).
Signiﬁcant differences were also noted in the rates of
ﬁbrous cap rupture between CC and OC stents (24.2%
vs 43.8%; p < 0.01), and between CC and Hyb stents (24.2%
vs 39.6%; p < 0.01), but not between OC vs Hyb stents
(p ¼ 0.4).
On a patient-based analysis (Table 6) plaque prolapse
was signiﬁcantly more common with OC (61.5%) compared
to CC stents (17.6%; p ¼ 0.02), while the rates of ﬁbrous
cap rupture were nearly signiﬁcant between CC and OC
stents (17.6% vs 53.8%; p ¼ 0.05). A non-signiﬁcant
statistical trend was also noted for the rate of struts mal-
apposition in patients treated by CC compared to those
treated by OC (41.6% vs 15.3%, p ¼ 0.2).
Table 7 shows an overview of demographic, clinical and
procedural data, correlated to the OCT ﬁndings in the two
patients suffering from TIA after CAS.
DISCUSSION
This is the ﬁrst study using OCT to assess carotid stent
apposition, plaque prolapse and ﬁbrous cap rupture
systematically following CAS. To date, limited informationTable 2. Overview of CAS materials.
Stent design n. (%)
Closed-cell 17 (42.5%)
Wallstent 13
Adapt 2
X-Act 2
Open-cell 13 (32.5%)
Precise Pro Rx 9
Protégé 4
Hybrid 10 (25%)
Cristallo Ideale 10has been available regarding the complex interaction
between carotid plaques and stents, considering that
neither angiography nor IVUS has the micro-scale resolution
capable of identifying such imperfections. OCT with its high-
resolution capability of 10 mm can detect them, and our
study has shown that in a relevant number of cases stent
strut malapposition, plaque prolapse or rupture of the
ﬁbrous cap persists despite technical success detected by
angiography.
Regardless of the use of an embolic protection device,
percutaneous treatment of carotid pathologies has been
correlated with a risk of cerebral ischaemic events related
to distal embolisation.17 Many factors may cause an intra-
procedural embolisation (including incorrect endoluminal
manoeuvres, complex aortic arch, use of cerebral protection
devices, stent deployment and ballooning, etc.),18 while
events occurring in the early postoperative period are
contemplated as the consequences of remodelling of the
atheroma, which is more or less contained behind the stent
struts.
Bosiers et al.19 reported different neurological rates after
CAS with different carotid stent designs. The study focussed
on post-procedural events (when the struts of the stent and
its scaffolding properties are the only protection against
plaque embolisation) and found that the symptomatic
population had an event rate highest when an OC type was
implanted.
These results opened the debate on the ability of plaque
coverage by distinctive stent designs. On the contrary,
another investigation20 has reported that carotid stent cell
design is not a determinant of neurologic complications,
and periprocedural and early post-procedural complications
may occur indifferently from the design of the implanted
stent. More recently a randomised controlled trial21 showed
that cerebral embolisation, as detected by transcranial
Doppler and diffusion-weighted MRI, occurs with similar
frequency after CAS with OC and CC stents.
Actually the precise mechanism for cerebral embolisation
after carotid stent implantation is still unknown: it is
obvious that plaque prolapse through the stent cell may be
responsible for neurological symptoms, but also stent mal-
apposition might play a role. Platelet micro-aggregation can
occur behind malapposed stent struts, which may act as
a ‘lightning rod’ for thrombus formation, which might then
embolise and cause a cerebrovascular event. Finally the
rupture of the ﬁbrous cap, even in a non-prolapsing plaque,
may also be the reason for late embolisation.
Our ﬁndings conﬁrm that, when interacting with the
plaque, all carotid stent designs are susceptible to those
micro-defects that are potentially responsible for cerebral
embolisation.
Incomplete coronary stent strut apposition has recently
received attention with studies suggesting an association
with an increased rate of long-term stent thrombosis.22,23
An OCT-based natural history study24 has revealed that
incomplete stent apposition without stent strut coverage in
coronary arteries is signiﬁcantly associated with the pres-
ence of OCT-detected thrombus at follow-up, which may
Table 3. Patient characteristics.
Total population
(n ¼ 40)
Closed-cell
design
(n ¼ 17)
Open-cell
design
(n ¼ 13)
Hybrid design
(n ¼ 10)
p-value
Male, No. (%) 26 (65%) 11 (64%) 8 (61%) 7 (70%) ns
Age (yrs) 73  3.8 74  2.6 73  3.1 72  2.9 ns
Neurological symptoms, No. (%) 17 (38%) 11 (64%) 2 (15%) 4 (40%) CC vs OC p ¼ 0.01
CC vs Hyb p ¼ ns
OC vs Hyb p ¼ ns
Hypertension, No. (%) 31 (77.5%) 12 (70%) 11 (84%) 8 (80%) ns
NIDDM, No. (%) 13 (32.5%) 6 (35%) 4 (31%) 3 (30%) ns
Smoker, No. (%) 18 (45%) 8 (47%) 5 (38%) 5 (50%) ns
CAD, No. (%) 12 (30%) 6 (35%) 3 (23%) 3 (30%) ns
Renal function (eGFR; mL/min/1.73 m2) 98  6.5 99  5.5 102  6.8 96  7.5 ns
Peripheral arterial disease, No. (%) 18 (45%) 8 (47%) 6 (46%) 4 (40%) ns
Hypercholesterolaemia, No. (%) 25 (62.5%) 11 (64%) 8 (62%) 6 (60%) ns
Side of carotid lesion (right), No. (%) 21 (52.5%) 9 (53%) 8 (62%) 4 (40%) ns
Restenosis after CEA, No. (%) 2 (5%) 1 (5%) 1 (8%) 0 (0%) ns
Carotid plaque compositiona, No. (%) ns
Type 1 6 (15%) 3 (18%) 1 (8%) 2 (20%) ns
Type 2 12 (30%) 5 (29%) 4 (31%) 3 (30%) ns
Type 3 15 (37.5%) 5 (29%) 6 (46%) 4 (40%) ns
Type 4 7 (17.5%) 1 (5%) 4 (31%) 2 (30%) ns
Carotid plaque ulceration, No. (%) 8 (20%) 4 (24%) 2 (15%) 2 (20%) ns
Legends: NIDDM ¼ non-insulin-dependent diabetes mellitus; CAD ¼ coronary artery disease; eGFR ¼ estimated glomerular ﬁltration rate;
CEA ¼ carotid endarterectomy.
a According to the Gray-Weale classiﬁcation.11
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Additionally the inﬂuence of stent design on stent strut
apposition has been investigated for coronary interven-
tion,25 but never for carotid intervention.
It is well known that actual designs of carotid stent have
distinctive features: CC stents have better coverage but less
conformability; OC stents adapt better to the vessel
anatomy but provide less coverage; and Hyb cell stents have
intermediate properties.
Surprisingly in our study only <60% of stent struts ana-
lysed by OCT were considered ‘well apposed’ to the arterial
wall. CC stent struts were more likely to be malapposed,
while OC stent struts were more likely to be embebbed
(p < 0.01). Moreover, plaque prolapse was more common
with OC stents compared to CC stents, but not to Hyb stents,
while ﬁbrous cap rupture occurred less frequently in the CC
stents compared to the OC or to the Hyb stents (p < 0.01).Table 4. Summary of stent apposition to the arterial wall on a stent s
Closed cell
(n ¼ 8655)
Open ce
(n ¼ 66
Malapposed struts 34.5% (2982) 15% (99
Embebbed struts 9% (783) 27% (17
Well apposed struts 56.5% (4890) 58% (38Of course we cannot exclude that OCT analysis at follow-
up might show better stent strut apposition and less
prolapse of plaque. In fact we know that the constant radial
force of self-expanding stents and the re-endothelisation
process might both play a role in this remodelling process
of the vessel after CAS.
Except for the rate of symptomatic lesions, which was
higher in the CC group (p ¼ 0.01), demographic and clinical
characteristics of the patients entered into our registry,
including age, carotid plaque composition and ulceration,
were not signiﬁcantly different from patients treated by
different stent designs (Table 3).
In spite of these apparently similar baseline patient
characteristics, we are aware that a number of potential
variables in addition to stent design may have inﬂuenced
the result detected by OCT (see section ‘Study limitations’).
For example, we may suppose that endovascular treatmenttrut-based analysis (total struts evaluated n ¼ 20,412).
ll
54)
Hybrid cell
(n ¼ 5103)
p-value
8) 16.3% (833) CC vs OC p < 0.01
CC vs Hyb p < 0.01
OC vs Hyb p ¼ 0.06
97) 25.6% (1310) CC vs OC p < 0.01
CC vs Hyb p < 0.01
OC vs Hyb p ¼ 1
59) 58.1% (2960) CC vs OC p ¼ 0.06
CC vs Hyb p ¼ 0.08
OC vs Hyb p ¼ 1
Table 5. Summary of OCT images results on a slice-based analysis (total slices evaluated n ¼ 729).
Closed cell
(n ¼ 305)
Open cell
(n ¼ 242)
Hybrid cell
(n ¼ 182)
p-value
Malappositiona 29.8%, (91) 13.2%, (32) 14.8%, (27) CC vs OC p < 0.01
CC vs Hyb p < 0.01
OC vs Hyb p ¼ 0.07
Plaque
prolapse
23.3%, (71) 68.6%, (166) 30.8%, (56) CC vs OC p < 0.01
CC vs Hyb p ¼ 0.08
OC vs Hyb p < 0.01
Rupture of
ﬁbrous cap
24.2%, (74) 43.8%, (106) 39.6%, (72) CC vs OC p < 0.01
CC vs Hyb p < 0.01
OC vs Hyb p ¼ 0.4
a At least 5 malapposed struts in a single slice.
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soft plaques may generate more plaque prolapse.
Fortunately no major neurological complications
occurred in our series. We counted only two TIAs (one in
the OC group, one in the Hyb group) that happened in
patients with symptomatic plaques. Notably both patients
presented at analysis of OCT frames (Table 6) a consistent
number of malapposed (15e20%) or embedded struts (25e
30%) associated to a high rate of plaque prolapse (55e70%)
and ﬁbrous cap rupture (40e45%).
Carotid plaque prolapse through cell stents have been
already described in all series of carotid OCT.6e11 Jones
et al.10 reported one case of OCT demonstration of a large
area of tissue prolapse through an OC stent immediately
after its implantation. This ﬁnding led to the decision to
deploy a further stent with a CC design and obtain the
resolution of the prolapse.
The main message from our investigation is that an
unexpected high number of micro-imperfections after CAS
are noticeable with all carotid stent designs. Although these
ﬁndings might all be potentially responsible for micro-
embolisation in the postoperative period with different
mechanisms, at the moment we cannot suggest any
particular change in the decision-making process after CAS.
In conclusion, it remains unknown whether these ﬁgures
now detected with OCT are of any clinical and prognostic
signiﬁcance. In fact the absence of clinical events at 30 days
suggests that the frequent persistence of these imperfec-
tions after CAS remains a benign phenomenon.Table 6. Summary of OCT images results on a patient-based analysis.
Closed cell
(n ¼ 17)
Open
(n ¼
Malappositiona 41.1%, (7) 15.3%
Plaque prolapseb 17.6%, (3) 61.5%
Rupture of ﬁbrous capc 17.6%, (3) 53.8%
a At least 25% of all the struts deﬁned as malapposed per patient.
b At least 10 appreciable tissue prolapses between the stent struts pe
c At least 10 discontinuities of the inner layer of the plaque proﬁle peStudy limitations
This is a single-centre study with a limited number of
patients. The ‘end’ points of the study are a surrogate
parameter instead of a clinical event. There are differences
in baseline patient data (number of symptomatic lesions)
that may have introduced a bias in favour of one speciﬁc
stent design.
The major limitation of this study is represented by the
absence of a multivariate analysis. The events of stent
malapposition, plaque prolapse or ﬁbrous cap rupture after
CAS are affected by several factors; some are patient-
related (age, cardiac disease, neurological status, diabetes,
etc.), some are lesion-related (plaque composition, ulcera-
tion, etc.), while others are stent-related (design, type, size,
etc.) or even procedure-related factors (need for pre-
dilatation, maximum dilatation pressure, operator’s experi-
ence, etc.).
Still there are some cross-relationships between the
various independent variables, which call for a multivariate
analysis. Unfortunately the small number of cases and the
large number of potential determinants made powerful
multivariate analysis impossible. Under such circumstances,
it was unreasonable to carry out an effective multivariate
analysis that should be needed in order to disentangle the
various expected effects.
The choice of the stent was made on operator’s prefer-
ence according to a tailored strategy26 that takes into
account plaque type, anatomy at the level of the culprit
lesion and patient’s symptoms. This may have introducedcell
13)
Hybrid cell
(n ¼ 10)
p-value
, (2) 20%, (2) CC vs OC p ¼ 0.2
CC vs Hyb p ¼ 0.6
OC vs Hyb p ¼ 1
, (8) 30%, (3) CC vs OC p ¼ 0.02
CC vs Hyb p ¼ 0.6
OC vs Hyb p ¼ 0.2
, (7) 40%, (4) CC vs OC p ¼ 0.05
CC vs Hyb p ¼ 0.3
OC vs Hyb p ¼ 0.6
r patient.
r patient.
Table 7. Clinical data and OCT ﬁndings in the two patients suffering neurological complication after CAS.
Patient 1 Patient 2
Demographic and clinical data
Age (years) 74 86
Neurological history Symptomatic Symptomatic
Carotid plaque composition Type 2 Type 2
Carotid plaque ulceration No No
Procedural data
Carotid stent design Open cell Hybrid
Carotid stent type Precise Cristallo ideale
Carotid stent size 8/40 mm 6e9/40 mm
Size of post-dilatation balloon 5.5 mm 5.5 mm
Maximum dilatation pressure 8 atm 10 atm
Complications
Type of neurological complication TIA TIA
Onset time of complications 1st day
(26 h after CAS)
1st day
(18 h after CAS)
OCT ﬁndingsa
Malapposed struts 17% (87/510) 14.9% (79/528)
Embebbed struts 30.6% (156/510) 25.9% (137/528)
Plaque prolapse Yes
(present in 15 out of
21 [71.5%] slices evaluated)
Yes
(present in 12 out of 22 [54.6%]
slices evaluated)
Fibrous cap rupture Yes
(present in 9 out of 21 [42.8%]
slices evaluated)
Yes
(present in 10 out of 22 [45.5%]
slices evaluated)
TIA ¼ transient ischaemic attack; CAS ¼ carotid artery stenting.
a Cross-sectional evaluation at 1 mm intervals within the stented segment of the internal carotid artery.
586 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 6 June/2013a bias in the study. A further study randomly allocating
a stent design to groups with different histological presen-
tation could be useful to actually verify the potential
different behaviour of stent design with intravascular OCT.
Finally, although the analysis of the images post proce-
dure was blinded, due to the unprecedented high-quality
assessment of strut apposition and plaque anatomy post
stenting, it is reasonable to consider that the two reviewers
became aware of the stent type during the images’ review
process. This may have introduced a bias in the results.
CONCLUSION
Despite technical success detected by angiography, intra-
vascular OCT after CAS revealed that stent malapposition,
plaque prolapse and ﬁbrous cap rupture are frequently
found and are related to the design of implanted stents.
In particular stent malapposition is more frequent with
CC stents, while plaque prolapse is more common with OC
stents.
Although the clinical impact of these ﬁndings still remains
to be determined, the result of this investigation seems to
offer some original and unexpected information, which is
available for the ﬁrst time at such high deﬁnition. The
careful and more detailed analysis of such results may
inﬂuence our future clinical policies in patients with carotid
artery disease.CONFLICT OF INTEREST/FUNDING
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